Product NewsClinical Diagnostics
Discover how the LumiraDx Platform has helped a community pharmacy evolve its point-of-care testing
12 Oct 2022
In this video, Niamh Boden, Dunville Community Pharmacy, discusses how the COVID-19 pandemic has evolved how pharmacies offer accessible community care and why she chose the LumiraDx Platform for point-of-care diagnostic testing.
About the company

LumiraDx
LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. Our technology provides fast, high performance and accessible diagnostic solutions at the point of need.
Other videos from LumiraDx
Links
Tags
Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.







